现在位置 >首页 > dubin98发表的所有文章
dubin98 ⁄ 发表于3年前 ⁄ 研究点评, 进展交流 ⁄ [Lancet Glob Health发表述评]:非洲的细菌耐药负担:准确性,行动以及其他已关闭评论
COMMENT|ONLINE FIRST Bacterial antimicrobial resistance burden in Africa: accuracy, action, and alternatives Sabiha Y Essack, A......
dubin98 ⁄ 发表于3年前 ⁄ 研究点评, 进展交流 ⁄ [ICU Management & Practice]: HOT-COVID临床试验- ISICEM 2024已关闭评论
Just Published: The HOT-COVID Clinical Trial - ISICEM 2024 In ICU Tue, 19 Mar 2024 Findings from the HOT-COVID Ra......
dubin98 ⁄ 发表于3年前 ⁄ 研究点评, 进展交流 ⁄ [JAMA发表述评]:你的里程可能有所不同:迈向个体化氧疗已关闭评论
Editorial  March 19, 2024 Your Mileage May Vary: Toward Personalized Oxygen Supplementation Derek C. Angus ......
dubin98 ⁄ 发表于3年前 ⁄ 研究点评, 进展交流 ⁄ [ICU Management & Practice]: 采用机器学习确定机械通气患者个体化氧合目标已关闭评论
Individualised Oxygen Targets in Mechanically Ventilated Patients Using Machine Learning New findings were presented at ISICEM......
dubin98 ⁄ 发表于3年前 ⁄ 时讯速递, 进展交流 ⁄ [JAMA发表论文]:妊娠期接种新冠病毒疫苗后新生儿的预后已关闭评论
Original Investigation  February 6, 2024 Neonatal Outcomes After COVID-19 Vaccination in Pregnancy Mikael Nor......
dubin98 ⁄ 发表于3年前 ⁄ 研究点评, 进展交流 ⁄ [ICU Management & Practice]: 脓毒症儿童的宿主基因表达已关闭评论
Host Gene Expression Signatures in Children Evaluated for Sepsis Findings presented at #ISICEM24 show that novel host transcri......
dubin98 ⁄ 发表于3年前 ⁄ 研究点评, 进展交流 ⁄ [JAMA发表述评]:新冠病毒感染患者的氧疗:多少才足够?已关闭评论
Editorial  March 19, 2024 Oxygen Supplementation in COVID-19—How Much Is Enough? Richard M. Schwartzstei......
dubin98 ⁄ 发表于3年前 ⁄ 研究点评, 进展交流 ⁄ [ICU Management & Practice]: 安全实施早期主动活动 – ISICEM 2024已关闭评论
Safe Application of Early Active Mobilisation - ISICEM 2024 Findings from a systematic review on early mobilisation were prese......
dubin98 ⁄ 发表于3年前 ⁄ 时讯速递, 进展交流 ⁄ [JAMA发表论文]:接受机械通气的危重病患者氧合目标的个体化治疗效果已关闭评论
Original Investigation  Caring for the Critically Ill Patient March 19, 2024 Individualized Treatment Effects......
dubin98 ⁄ 发表于3年前 ⁄ 研究点评, 进展交流 ⁄ [ICU Management & Practice]: ISICEM开幕已关闭评论
ISICEM 2024 Begins! The 43rd International Symposium on Intensive Care and Emergency Medicine (ISICEM) opened today in Brussel......
×
腾讯微博